Verition Fund Management
ANGO icon

Verition Fund Management’s AngioDynamics ANGO Stock Holding History

Verition Fund Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-77,786
Closed -$999K – 2275
2025
Q4 		$999K Buy
77,786
+31,332
+67% +$387K ﹤0.01% 2158
2025
Q3 		$519K Sell
46,454
-67,144
-59% -$648K ﹤0.01% 3001
2025
Q2 		$1.13M Buy
+113,598
New +$1.11M 0.01% 2385
2025
Q1 		– Sell
-19,576
Closed -$179K – 3308
2024
Q4 		$179K Buy
+19,576
New +$144K ﹤0.01% 3004
2024
Q3 		– Sell
-24,740
Closed -$150K – 3162
2024
Q2 		$150K Sell
24,740
-33,767
-58% -$208K ﹤0.01% 2669
2024
Q1 		$343K Buy
58,507
+3,383
+6% +$20.1K ﹤0.01% 2217
2023
Q4 		$432K Sell
55,124
-27,185
-33% -$189K ﹤0.01% 1588
2023
Q3 		$602K Buy
82,309
+7,135
+9% +$59.4K 0.01% 1323
2023
Q2 		$784K Buy
75,174
+1,032
+1% +$9.93K 0.01% 1017
2023
Q1 		$767K Buy
74,142
+62,758
+551% +$803K 0.01% 1048
2022
Q4 		$157K Buy
+11,384
New +$158K ﹤0.01% 1797
2020
Q4 		– Sell
-29,822
Closed -$360K – 1082
2020
Q3 		$360K Buy
+29,822
New +$283K 0.01% 711

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $118M AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $295M AUM 19.08% 1-Year Est. Return

Verition Fund Management's ANGO Position: Q1 2026 in Review

Verition Fund Management sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 77,786 shares — an estimated $999K sold.

Verition Fund Management first reported a position in ANGO in Q3 2020 and held it in 12 quarters. The position peaked at $1.13M in Q2 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Verition Fund Management reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 77,786 AngioDynamics shares in Q1 2026, an estimated $999K.
  • Verition Fund Management first reported a position in AngioDynamics in Q3 2020 and held it in 12 quarters.
  • Verition Fund Management's AngioDynamics position peaked at $1.13M in Q2 2025.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.